Agenus

AGENNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$379.360 M

$8.40 -3.45%

Close of 23 Sept 2026

Revenue

$114.2M

#2461 by revenue

Earnings

-$3.08M

Loss-making

Shares outstanding

45,020,407

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#72Zura BioZURA$414.9M
#73Editas MedicineEDIT$413.1M
#74AgenusAGEN$379.4M
#75C4 TherapeuticsCCCC$378.9M
#76Artiva BiotherapeuticsARTV$377.4M

What if Agenus were worth as much as…

Open the what-if tool →

Gold $29.8T

$660,887.08

Per share 78,677× higher

Bitcoin $1.69T

$37,512.15

Per share 4,466× higher

Nvidia $5.43T

$120,340.13

Per share 14,326× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Agenus are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 24 Sept 2026. Read the methodology.